A detailed history of New York State Common Retirement Fund transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, New York State Common Retirement Fund holds 14,279 shares of PRTA stock, worth $258,449. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,279
Previous 18,379 22.31%
Holding current value
$258,449
Previous $379,000 36.94%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$16.73 - $24.79 $68,593 - $101,639
-4,100 Reduced 22.31%
14,279 $239,000
Q2 2024

Jul 31, 2024

SELL
$19.54 - $26.15 $272,993 - $365,341
-13,971 Reduced 43.19%
18,379 $379,000
Q1 2024

May 07, 2024

SELL
$24.75 - $40.66 $32,125 - $52,776
-1,298 Reduced 3.86%
32,350 $801,000
Q4 2023

Feb 01, 2024

BUY
$32.31 - $52.32 $86,429 - $139,956
2,675 Added 8.64%
33,648 $1.22 Million
Q3 2023

Nov 07, 2023

SELL
$47.3 - $70.6 $9,554 - $14,261
-202 Reduced 0.65%
30,973 $1.49 Million
Q2 2023

Aug 07, 2023

SELL
$48.26 - $78.59 $19,304 - $31,436
-400 Reduced 1.27%
31,175 $2.13 Million
Q1 2023

May 02, 2023

SELL
$46.97 - $58.27 $197,508 - $245,025
-4,205 Reduced 11.75%
31,575 $1.53 Million
Q4 2022

Jan 30, 2023

SELL
$52.05 - $65.0 $31,802 - $39,715
-611 Reduced 1.68%
35,780 $2.16 Million
Q3 2022

Nov 08, 2022

BUY
$25.16 - $60.63 $41,916 - $101,009
1,666 Added 4.8%
36,391 $2.21 Million
Q2 2022

Aug 04, 2022

SELL
$22.73 - $39.98 $121,560 - $213,813
-5,348 Reduced 13.35%
34,725 $943,000
Q1 2022

May 05, 2022

BUY
$30.27 - $49.22 $281,268 - $457,352
9,292 Added 30.19%
40,073 $1.47 Million
Q4 2021

Feb 02, 2022

BUY
$42.11 - $73.26 $186,168 - $323,882
4,421 Added 16.77%
30,781 $1.52 Million
Q3 2021

Nov 02, 2021

SELL
$48.2 - $78.89 $180,750 - $295,837
-3,750 Reduced 12.45%
26,360 $1.88 Million
Q2 2021

Aug 02, 2021

BUY
$21.63 - $57.65 $50,635 - $134,958
2,341 Added 8.43%
30,110 $1.55 Million
Q2 2020

Aug 07, 2020

SELL
$9.56 - $12.51 $97,512 - $127,602
-10,200 Reduced 26.86%
27,769 $290,000
Q3 2019

Nov 07, 2019

SELL
$6.89 - $10.45 $27,084 - $41,078
-3,931 Reduced 9.38%
37,969 $298,000
Q2 2019

Aug 09, 2019

BUY
$8.85 - $12.49 $2,655 - $3,747
300 Added 0.72%
41,900 $443,000
Q2 2018

Aug 10, 2018

SELL
$10.99 - $44.21 $712,130 - $2.86 Million
-64,798 Reduced 60.9%
41,600 $607,000
Q4 2017

Feb 13, 2018

BUY
$35.44 - $63.76 $407,489 - $733,112
11,498 Added 12.12%
106,398 $3.99 Million
Q3 2017

Nov 06, 2017

BUY
$53.83 - $67.75 $2.87 Million - $3.61 Million
53,300 Added 128.13%
94,900 $6.15 Million
Q2 2017

Aug 11, 2017

BUY
N/A
41,600
41,600 $2.25 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $849M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.